Venous Thromboembolism (VTE) is common in patients undergoing treatment for brain tumors. American College of Chest Physicians (ACCP) 2004 consensus conference recommends routine use of intermittent ...
"We still have a lot of work ahead to define what the most informative prediction/scoring VTE systems are, for both newly diagnosed and relapsed/refractory MM patients, and how we can make them more ...
The earliest published study on this topic was a retrospective case–control study by Northup and associates [8] focusing on 113 inpatients with cirrhosis who had newly diagnosed VTE during hospital ...
Please provide your email address to receive an email when new articles are posted on . A dynamic learner-centered education module appeared more effective than a linear static education module for ...
Venous thromboembolism (VTE) is a leading cause of hospital deaths in the U.S., but about 70 percent of healthcare-associated VTE cases are preventable with the right team and data approach. During a ...
Obesity is associated with an increased risk of VTE, and it has been postulated that standard prophylactic LMWH doses may be insufficient to prevent VTE or achieve suggested anti-factor Xa target ...
Stakeholders concurred that the occurrence of VTE events is a significant public health concern. According to Ralph J. Riello III, PharmD, “It is a problem often that hospitals do not know that they ...
Paul P. Dobesh, PharmD, explained that the approval of betrixaban was important for several reasons: VTE events continue to occur during hospitalization and following discharge, despite the standard ...
Multicenter phase III trial of adjuvant chemoradiotherapy in stomach tumors 2 (ARTIST 2). Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback